恶性肿瘤患者应用紫杉醇化疗过程中合并心肌损伤的影响因素分析OACSTPCD
Analysis of influencing factors for concurrent myocardiac injury in patients with malignant tumor during paclitaxel chemotherapy
目的 分析恶性肿瘤患者应用紫杉醇化疗过程中合并心肌损伤的影响因素.方法 选取 2017 年 9 月至 2022 年 9 月期间在简阳市人民医院使用紫杉醇进行化疗的恶性肿瘤患者,共 110 例.回顾性分析患者的临床资料,将出现心肌损伤的患者作为观察组(35 例),未出现心肌损伤患者作为对照组(75 例),比较两组患者的临床资料.将单因素分析中存在差异的多个因素纳入多因素Logistic回归模型分析恶性肿瘤患者应用紫杉醇化疗过程合并心肌损伤的影响因素…查看全部>>
Objective To analyze the influencing factors for concurrent myocardial injury in malignant tumor patients during paclitaxel chemotherapy.Methods A total of 110 malignant tumor patients who received paclitaxel chemotherapy at Jianyang People's Hospital from September 2017 to September 2022 were selected.Clinical data of the patients were retrospectively analyzed.Patients were divided into two groups:35 patients with myocardial injury in the observation group …查看全部>>
翁莉萍;蒋景奎
641400 四川省简阳市人民医院肿瘤科二区641400 四川省简阳市人民医院心内科
紫杉醇恶性肿瘤心肌损伤化疗
PaclitaxelMalignant tumorMyocardial injuryChemotherapy
《心脑血管病防治》 2024 (5)
23-26,4
评论